Fundraising Fox

Willett Advisors

Family office

New York

Fox Verdict
Sign up to see your fit

Investment thesis

Willett Advisors seeks long-term capital appreciation by constructing a diversified investment portfolio. Operating like many endowments, foundations, and family offices, it invests both directly and through selected third-party managers across a broad range of asset classes, including public markets, hedge funds, private equity and credit, real assets, and direct investments. The firm manages the philanthropic assets of Michael R. Bloomberg and Bloomberg Philanthropies from its New York headquarters.

Source: firm website, verified Aug 3, 2026.

HQ
New York, US
Instruments
Equity · Debt
Last 12 months
2 investments
Tracked investments
3

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Healthtech ×2Advanced Manufacturing ×1Medical Devices ×1

HQs:United States×3

Investments · 3 tracked

founders shown can be your intro path

By year:2026 · 22025 · 13 dated

Cellarescellares.cominJan 2026 · $257M

Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.

Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US

Fabian Gerlinghaus(Co-Founder and Chief Executive Officer)inOmar Kurdi(Co-Founder and President)in

BoardJustin Butler(Director)inVictor Tong(Director)in

Co-investorsDecheng Capital8VCEcoR1 CapitalIntuitive VenturesKoch Disruptive TechnologiesBaillie Gifford+4 more

Kinaset Therapeuticskinasettherapeutics.comin𝕏Jan 2026

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)Frazer Morgan(Chief Development Officer / Co-Founder)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesSixty Degree CapitalVivo Capital+1 more

Neurona Therapeuticsneuronatherapeutics.cominApr 2025 · $102M

Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.

BiotechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)James Stutz(Executive Officer)Arnold Kriegstein(Director)

BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)

Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more

Portfolio news

latest coverage across their companies

Frequently asked questions

What sectors does Willett Advisors focus on?
Willett Advisors focuses on Crypto & Web3.
Where is Willett Advisors located?
Willett Advisors is headquartered in New York, US.

Images

Willett Advisors photo

Similar investors

Featured in lists